• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去细胞化作为一种减少牛心包生物瓣膜钙化的方法。

Decellularization as a method to reduce calcification in bovine pericardium bioprosthetic valves.

作者信息

Collatusso Claudinei, Roderjan João Gabriel, de Noronha Lucia, Klosowski Allyson, Suss Paula Hansen, Guarita-Souza Luiz César, Costa Francisco Diniz Affonso da

机构信息

Department of Cardiac Surgery, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil.

Department of Biochemistry, PUCPR, Curitiba, Brazil.

出版信息

Interact Cardiovasc Thorac Surg. 2019 Aug 1;29(2):302–311. doi: 10.1093/icvts/ivz041. Epub 2019 Mar 8.

DOI:10.1093/icvts/ivz041
PMID:30848795
Abstract

OBJECTIVES

Decellularization is an alternative method for processing biological tissues with decreased antigenicity and resistance to calcification. The aim of this study was to characterize the properties of decellularized (dCell) bovine pericardium fixed with 0.1% glutaraldehyde (GA) and to evaluate outcomes of bioprosthetic valves constructed with this tissue when implanted in the mitral position of juvenile sheep.

METHODS

Bioprosthetic mitral valves were constructed with fresh bovine pericardium fixed in 0.5% GA (control group) or dCell bovine pericardium fixed in 0.1% GA (study group). Before implantation, samples were submitted to histological (haematoxylin-eosin, Movat and 4',6-diamidino-2-phenylindole), biochemical (residual deoxyribonucleic acid and α-gal epitopes) and biomechanical characterization. Valves were implanted (n = 8 in each group) as a mitral valve replacement for 180 days in sheep and explants were re-evaluated histologically and for calcification with radiological studies and calcium content determination.

RESULTS

Unimplanted dCell pericardia exhibited a well-preserved extracellular matrix with absence of cells, a 77% reduction in deoxyribonucleic acid levels and with no detectable α-gal epitopes. When compared to controls, they had lower ultimate tensile strength (7.3 ± 5.4 vs 10.2 ± 3.0 mPa, P = 0.04) and greater percentage elongation in the longitudinal direction (29 ± 6.5% vs 23.8 ± 5.1%, P = 0.02). After 180 days in mitral position, dCell valves showed pliable leaflets without macroscopic signs of calcification. Histologically, dCell leaflets had intact collagen fibres, better tissue remodelling and a significant 89% reduction in calcium content.

CONCLUSIONS

This study demonstrates that bioprosthetic valves constructed with dCell bovine pericardium fixed in low GA concentration were resistant to calcification and may thereby improve long-term durability of the tissue.

摘要

目的

去细胞化是一种处理生物组织的替代方法,可降低抗原性并提高抗钙化能力。本研究的目的是表征用0.1%戊二醛(GA)固定的去细胞化(dCell)牛心包的特性,并评估用该组织构建的生物瓣膜植入幼年绵羊二尖瓣位置后的效果。

方法

用固定于0.5% GA的新鲜牛心包(对照组)或固定于0.1% GA的dCell牛心包(研究组)构建生物二尖瓣。植入前,对样本进行组织学(苏木精-伊红、Movat和4',6-二脒基-2-苯基吲哚)、生化(残留脱氧核糖核酸和α-半乳糖表位)和生物力学表征。将瓣膜植入绵羊体内(每组n = 8)作为二尖瓣置换物,持续180天,然后对外植体进行组织学重新评估,并通过放射学研究和钙含量测定评估钙化情况。

结果

未植入的dCell心包显示细胞外基质保存良好,无细胞,脱氧核糖核酸水平降低77%,且未检测到α-半乳糖表位。与对照组相比,其极限抗拉强度较低(7.3±5.4 vs 10.2±3.0 mPa,P = 0.04),纵向伸长百分比更高(29±6.5% vs 23.8±5.1%,P = 0.02)。在二尖瓣位置放置180天后,dCell瓣膜的瓣叶柔韧,无宏观钙化迹象。组织学上,dCell瓣叶的胶原纤维完整,组织重塑更好,钙含量显著降低89%。

结论

本研究表明,用低GA浓度固定的dCell牛心包构建的生物瓣膜具有抗钙化能力,从而可能提高组织的长期耐久性。

相似文献

1
Decellularization as a method to reduce calcification in bovine pericardium bioprosthetic valves.去细胞化作为一种减少牛心包生物瓣膜钙化的方法。
Interact Cardiovasc Thorac Surg. 2019 Aug 1;29(2):302–311. doi: 10.1093/icvts/ivz041. Epub 2019 Mar 8.
2
In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse.用敲除α1,3-半乳糖基转移酶的小鼠研究α-半乳糖苷酶对生物瓣耐久性延长的体内疗效。
Tissue Eng Part A. 2013 Nov;19(21-22):2339-48. doi: 10.1089/ten.TEA.2013.0062. Epub 2013 Jun 18.
3
The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.α1,3-半乳糖基转移酶基因敲除小鼠生物假体的免疫反应与钙化
J Heart Valve Dis. 2016 Mar;25(2):253-261.
4
Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.去细胞化、溶剂处理和基因素与戊二醛固定牛心包的解毒处理对钙化的抑制作用。
Eur J Cardiothorac Surg. 2012 Feb;41(2):383-90. doi: 10.1016/j.ejcts.2011.05.016. Epub 2011 Dec 12.
5
Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue.在α-半乳糖基因敲除小鼠植入模型中脱细胞和经α-半乳糖苷酶处理的牛心包组织的钙化:与灵长类心包组织的比较
Eur J Cardiothorac Surg. 2016 Mar;49(3):894-900. doi: 10.1093/ejcts/ezv189. Epub 2015 May 20.
6
Comparison of tensile properties of xenopericardium from three animal species and finite element analysis for bioprosthetic heart valve tissue.三种动物源生物心包材料拉伸性能比较及生物瓣组织的有限元分析。
Artif Organs. 2020 Mar;44(3):278-287. doi: 10.1111/aor.13552. Epub 2019 Sep 1.
7
Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.一种新型心包生物假体(由染料介导的光氧化牛心包组织制成)的可行性评估。
J Heart Valve Dis. 1996 May;5(3):317-22.
8
A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.一种使用亚硫酸氢钠修饰牛心包的新型抗钙化策略。
J Heart Valve Dis. 2009 Mar;18(2):180-5; discussion 186.
9
Collagen fibre-mediated mechanical damage increases calcification of bovine pericardium for use in bioprosthetic heart valves.胶原纤维介导的机械损伤增加牛心包钙化用于生物瓣心脏瓣膜。
Acta Biomater. 2021 Jul 1;128:384-392. doi: 10.1016/j.actbio.2021.04.046. Epub 2021 May 1.
10
Advantages of decellularized bovine pericardial scaffolds compared to glutaraldehyde fixed bovine pericardial patches demonstrated in a 180-day implant ovine study.脱细胞牛心包支架相对于戊二醛固定牛心包补片的优势在为期 180 天的植入绵羊研究中得到证实。
Cell Tissue Bank. 2022 Dec;23(4):791-805. doi: 10.1007/s10561-021-09988-8. Epub 2022 Jan 17.

引用本文的文献

1
Monomeric glutaraldehyde fixation and amino acid detoxification of decellularized bovine pericardium for production of biocompatible tissue with tissue-guided regenerative potential.用于生产具有组织引导再生潜力的生物相容性组织的去细胞牛心包的单体戊二醛固定和氨基酸解毒处理
Heliyon. 2023 Sep 1;9(9):e19712. doi: 10.1016/j.heliyon.2023.e19712. eCollection 2023 Sep.
2
In vitro evaluation of crosslinked bovine pericardium as potential scaffold for the oral cavity.体外评估交联牛心包作为口腔潜在支架材料。
Biomed Mater Eng. 2023;34(6):561-575. doi: 10.3233/BME-230027.
3
Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method.
通过一种新型抗原去除方法提高生物人工心脏瓣膜体内免疫耐受性的初步研究。
Front Bioeng Biotechnol. 2023 Mar 27;11:1141247. doi: 10.3389/fbioe.2023.1141247. eCollection 2023.
4
Ultrastructural and Immunohistochemical Detection of Hydroxyapatite Nucleating Role by rRNA and Nuclear Chromatin Derivatives in Aortic Valve Calcification: In Vitro and In Vivo Pro-Calcific Animal Models and Actual Calcific Disease in Humans.在主动脉瓣钙化中 rRNA 和核染色质衍生物对羟磷灰石成核作用的超微结构和免疫组织化学检测:体外和体内促钙化动物模型以及人类实际钙化疾病。
Int J Mol Sci. 2023 Jan 31;24(3):2667. doi: 10.3390/ijms24032667.
5
Preclinical Large Animal Experiments for Surgically Implanted Atrioventricular Valve: Reappraisal and Systematic Review.经导管植入式房室瓣的临床前大型动物实验:重新评估与系统综述。
Curr Cardiol Rev. 2023;19(1):e170622206130. doi: 10.2174/1573403X18666220617115216.
6
Improved Cytocompatibility and Reduced Calcification of Glutaraldehyde-Crosslinked Bovine Pericardium by Modification With Glutathione.通过谷胱甘肽修饰提高戊二醛交联牛心包的细胞相容性并减少钙化
Front Bioeng Biotechnol. 2022 May 19;10:844010. doi: 10.3389/fbioe.2022.844010. eCollection 2022.
7
Promotion of right ventricular outflow tract reconstruction using a novel cardiac patch incorporated with hypoxia-pretreated urine-derived stem cells.使用一种结合低氧预处理尿源干细胞的新型心脏补片促进右心室流出道重建。
Bioact Mater. 2021 Nov 30;14:206-218. doi: 10.1016/j.bioactmat.2021.11.021. eCollection 2022 Aug.
8
Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves.心包生物人工心脏瓣膜的长期稳定性和生物相容性
Front Cardiovasc Med. 2021 Sep 13;8:728577. doi: 10.3389/fcvm.2021.728577. eCollection 2021.
9
Preclinical study of a self-expanding pulmonary valve for the treatment of pulmonary valve disease.一种用于治疗肺动脉瓣疾病的自膨式肺动脉瓣的临床前研究。
Regen Biomater. 2020 Aug 22;7(6):609-618. doi: 10.1093/rb/rbaa035. eCollection 2020 Dec.